Melhorn, Philipp
Raderer, Markus
Mazal, Peter
Kozakowski, Nicolas
Kiesewetter, Barbara http://orcid.org/0000-0002-5490-2371
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 2 February 2024
Accepted: 2 April 2024
First Online: 29 April 2024
Declarations
:
: P. Melhorn, M. Raderer, P. Mazal, N. Kozakowski and B. Kiesewetter report no relevant conflicts of interest for this paper. M. Raderer received honoraria for lectures or advisory board participation from the following for-profit companies (all outside of the submitted work): Celgene/BMS, Ipsen, Novartis, Roche, Eisai, Eli Lilly. B. Kiesewetter received honoraria for lectures or advisory board participation from the following for-profit companies (all outside of the submitted work): AAA, Boehringer Ingelheim, Ipsen, Novartis, MSD, Eli Lilly, Janssen Cilag.
: Ethics committee approval and patient consent is not required for this study in accordance with local or national guidelines.